Adam B. Mayerson
- Molecular Biology top 10%
- Epidemiology top 5%
- Physiology top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Surgery
- Co-authors
- Silvio E. InzucchiRipudaman S. HundalGerald I. ShulmanKitt Falk PetersenSteven E. ShoelsonSylvie DufourVincent LebonGary W. Cline
- Topics
- Peroxisome Proliferator-Activated Receptors (4 papers)Adipokines, Inflammation, and Metabolic Diseases (3 papers)NF-κB Signaling Pathways (2 papers)
- Partner nations
- United States
In The Last Decade
Adam B. Mayerson
8 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 713
- Epidemiology 625
- Physiology 587
- Endocrinology, Diabetes and Metabolism 464
- Surgery 239
Countries citing papers authored by Adam B. Mayerson
This map shows the geographic impact of Adam B. Mayerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam B. Mayerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam B. Mayerson more than expected).
Fields of papers citing papers by Adam B. Mayerson
This network shows the impact of papers produced by Adam B. Mayerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam B. Mayerson. The network helps show where Adam B. Mayerson may publish in the future.
Co-authorship network of co-authors of Adam B. Mayerson
This figure shows the co-authorship network connecting the top 25 collaborators of Adam B. Mayerson. A scholar is included among the top collaborators of Adam B. Mayerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam B. Mayerson. Adam B. Mayerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 12 | |
| 3 | 0 | |
| 4 | 39 | |
| 5 | 35 | |
| 6 | 439 | |
| 7 | 8 | |
| 8 | 495 | |
| 9 | The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetesbreakdown → | 536 |
About Adam B. Mayerson
Adam B. Mayerson is a scholar working on Endocrinology, Diabetes and Metabolism, Occupational Therapy and Cancer Research, having authored 9 papers that have together received 1.6k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (464 citations), Physiology (587 citations) and Epidemiology (625 citations). Adam B. Mayerson has collaborated with scholars based in United States. Frequent co-authors include Silvio E. Inzucchi, Ripudaman S. Hundal, Gerald I. Shulman, Kitt Falk Petersen, Steven E. Shoelson, Sylvie Dufour, Vincent Lebon, Gary W. Cline, Douglas E. Befroy and Oluwole Fadare. Their work appears in journals such as Journal of Clinical Investigation, Diabetes and Endocrine Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.